Key statistics
On Thursday, Arrowhead Pharmaceuticals Inc (HDP1:BRN) closed at 22.53, 0.00% below its 52-week high of 22.53, set on Jul 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 22.53 |
---|---|
High | 22.53 |
Low | 22.53 |
Bid | 22.52 |
Offer | 22.81 |
Previous close | 22.53 |
Average volume | -- |
---|---|
Shares outstanding | 138.10m |
Free float | 118.88m |
P/E (TTM) | -- |
Market cap | 2.22bn USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of Jul 04 2024.
More ▼
Press releases
- Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
- Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
- Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
- Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
- Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
More ▼